The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Open accessAbstract
Complex interactions between the immune system and the brain might have important aetiological and therapeutic implications for neuropsychiatric brain disorders. A possible association between schizophrenia and the immune system was postulated over a century ago, and is supported by epidemiological and genetic studies pointing to links with infection and inflammation. Contrary to the traditional view that the brain is an immunologically privileged site shielded behind the blood-brain barrier, studies in the past 20 years have noted complex interactions between the immune system, systemic inflammation, and the brain, which can lead to changes in mood, cognition, and behaviour. In this Review, we describe some of the important areas of research regarding innate and adaptive immune response in schizophrenia and related psychotic disorders that, we think, will be of interest to psychiatric clinicians and researchers. We discuss potential mechanisms and therapeutic implications of these findings, including studies of anti-inflammatory drugs in schizophrenia, describe areas for development, and offer testable hypotheses for future investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“according to the immune hypothesis of psychiatric diseases, therapeutic control of peripheral and brain inflammation could offer novel, important tools in the treatment of severe mental and mood disorders, such as major depression (Khandaker et al. 2015; Miller and Raison 2016).”
From Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment (2020) · cites this paper as Khandaker et al. 2015
In the citing paper
“These triggers can induce inflammatory changes that are associated with reduced neurotransmitter signaling, increased oxidative stress, and reduced synaptic branching [118].”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Immunobiology: the immune system in health and disease
(1995) · Choice Reviews Online · doi:10.5860/choice.32-3876 · Cited by 4,111
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cited by
Sorted by citations
Items 901–931 of 931
Inflammation’s complex role in first-episode psychoses
Byeon, H. (2026) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry_502_25
Gao, X., Wang, T., He, Y., Huang, X., Song, Z., Lv, M., Zhong, Z., Huang, Y., Su, L., & Long, J. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120756
A Narrative Review of Neuroimmune Mechanisms Linking Inflammation and Psychological Symptoms in IBS
Stark, V., Asefirad, A., Kovaltchouk, I., Pitts, A., & Stone, A. E. L. (2026) · Advanced Gut & Microbiome Research · doi:10.1155/agm3/6281013
Yoshimachi, F., Ikuta, M., Kimura, K., Wang, H., Fu, J., Kirikae, H., Kumar, A., Shima, Y., Yamamoto, Y., Miyazaki, H., et al. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111921
Liu, W., Xia, X., Hong, Z., Deng, Z., Zhu, F., Zhang, K., Kang, S., Wei, Q., Tao, J., & Li, L. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.09.031
Maunder, K., Geraghty, L., Glennon, J. C., Jordan, E., Bhalla, D., Dehestani, B., & McNicholas, F. (2026) · JAACAP Open · doi:10.1016/j.jaacop.2026.09.005
Concomitant pathologies and their impact on schizophrenia: a narrative overview of current evidence
Jellinger, K. A. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03293-y
Long, X., Zhang, M., Cheng, P., Wang, F., Wang, Y., Liu, X., Huang, W., Chen, G., 刘哲宁, Yang, J., et al. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.09.024
Yang, Y., Liu, B., Cao, Z., Fang, H., Guo, Y., Jiang, T., Lü, Y., 曲, 淑., Tang, Q., Wang, Y., et al. (2026) · Metabolites · doi:10.3390/metabo16100733
Ergün, M. T., Aydın, M., Tekdemir, R., Bayırlı, Ö., Gürses, K. M., Yalçın, M. U., Özalp, H., Artaç, H., Ceylan, A., Abuşoğlu, S., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101370
Sun, D., Zhang, C., Hou, M., & Zhao, H. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06253-5
Chapter 2. Inflammation in the Brain and the Body
(2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550930.lg02
Lado, L. A., & Misir, A. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1941148
Brzezicki, M. A., Zakowicz, P. T., Kapelski, P., Wiłkość-Dębczyńska, M., Rajewska‐Rager, A., & Skibińska, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1936750
Roméo, B., Jeannin, J., Lestra, V., Martelli, C., Amirouche, A., Benyamina, A., & Hamdani, N. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.10.006
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0003
Gough, J. (2026) · doi:10.1093/9780197836088.001.0001
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0007
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0014
Introduction: Conceptual Breakage
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.002.0004
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0005
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0006
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0010
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0016
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0002
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0008
Human Beings and Their Make-Up
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0013
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0015
Intuitive Dualism and Human Specialness
Gough, J. (2026) · Oxford University Press eBooks · doi:10.1093/9780197836088.003.0011
BindingDB Entry 50018428: Progress in mechanistically novel treatments for schizophrenia.
BindingDB (2024) · UC San Diego · doi:10.7270/q2fr01sz
C-Reactive Protein Levels and Elevations in Schizophrenia: The Central Role of Body Mass Index
Yolken, R. H., Khan, S., Origoni, A. E., Rowe, K. C., Katsafanas, E., Mukhtar, F., Calahatian, A. T., Yang, S., & Dickerson, F. (2026) · Schizophrenia Bulletin · doi:10.1093/schbul/sbag152
Self-citation
Metadata
- Authors
- Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B.
- Affiliations
- University of Cambridge (GB)
- University of Oxford (GB)
- Johns Hopkins University (US)
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 2
- Issue
- 3
- Pages
- 258-270
- ISSN
- 2215-0366 (ISSN-L)
- PMC
- PMC4595998
- OpenAlex
- W2121637331
- Cited by
- 926
- References
- 135
- Citations by year
- 2026: 82 · 2025: 81 · 2024: 111 · 2023: 104 · 2022: 94 · 2021: 105 · 2020: 78 · 2019: 86 · 2018: 62 · 2017: 63 · 2016: 54 · 2015: 5
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Apollo (University of Cambridge) (acceptedVersion)
- Explore Bristol Research (submittedVersion)
- Funders
- Wellcome Trust to GMK ((094790/Z/10/Z; 2010-'13))
- National Institute of Mental Health ((MH-94268))
- Wellcome Trust ((095844/Z/11/Z and 088869/Z/09/Z))
- National Institute for Health Research ((RP-PG-0606–1335))
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- schizophrenia, inflammation, immunity, innate immune response, adaptive immune response, infection, blood-brain barrier, anti-inflammatory agents, psychosis, pathophysiology, treatment
- MeSH terms
- Humans, Immune System, Inflammation, Schizophrenia, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
